VVOS - Vivos Therapeutics GAAP EPS of -$0.26 in-line revenue of $3.46M misses by $0.98M May, 16 2022 04:11 PM Vivos Therapeutics Inc. Vivos Therapeutics press release (NASDAQ:VVOS): Q1 GAAP EPS of -$0.26 in-line. Revenue of $3.46M (+0.3% Y/Y) misses by $0.98M. For further details see: Vivos Therapeutics GAAP EPS of -$0.26 in-line, revenue of $3.46M misses by $0.98M